Biotech Values

[DewDiligence]

MNTA Insider Shareholdings

[Updated for SEC filings through 8/20/08.
The new General Counsel, Bruce Leicher,
received a grant of 25K restricted shares.]

 
 Executive Officers  
 Craig Wheeler, CEO         350K shares   475K options 
 G. Venkataraman, CSO       458K shares   145K options 
 Steven Brugger, COO        263K shares   168K options 
 *John Bishop, SVP Pharma    39K shares   166K options 
 †Bruce Leicher, Gen Counsel 25K shares      0 options 
 ‡James Roach, CMO             0 shares   163K options 
 Richard Shea, CFO           28K shares   208K options 
 -- 
 Six executive officers   1,163K shares 1,325K options

 
 Non-executive directors  
 Peter Barrett (Atlas)    2,459K shares    96K options 
 John Clarke                 77K shares    96K options 
 Alan Crane (Polaris)       580K shares    74K options 
 Marsha Fanucci                0 shares    96K options 
 Peter Hutt                  67K shares   176K options 
 Robert Langer              950K shares    96K options 
 *Ram Sasisekharan          406K shares    96K options 
 *Bennett Shapiro             5K shares   124K options 
 Elizabeth Stoner              0 shares    49K options 
 **James Sulat                 0 shares      0 options 
 -- 
 10 non-executive dirctrs 4,544K shares   903K options

 
 All officers/directors   5,707K shares 2,228K options 
  
 *10b5-1 selling plan in effect. 
 **Elected to BoD 6/5/08. 
 †Hired 7/24/08. 
 ‡Hired 2/26/08.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”